Literature DB >> 1569306

Pneumococcal bacteraemia during a recent decade.

A Kuikka1, J Syrjänen, O V Renkonen, V V Valtonen.   

Abstract

We retrospectively reviewed 159 episodes of bacteraemic pneumococcal infection in 157 adult patients at the Helsinki University Central Hospital during two periods between 1976 and 1979 and 1986 and 1989. We looked especially at changes in underlying diseases and prognostic factors. The overall case fatality rate was 21% and there was a small diminishing trend in that rate from 28% (16/58) in the late 1970s to 17% (17/101) in the late 1980s. The patients who died in the late 1980s were younger than those who died in the earlier period. The most common underlying factors were alcohol abuse, cardiovascular diseases and chronic obstructive pulmonary diseases. Old age was neither a predisposing factor nor did it predict the outcome. No significant changes in underlying diseases or prognostic factors were noted during the two periods studied except a small decrease in connective tissue diseases as underlying conditions. The factors related to increased fatality included hepatic cirrhosis, a combination of pneumonia and meningitis, complications such as shock, respiratory insufficiency, central nervous system disorders and circulatory acidosis, and laboratory findings such as thrombocytopenia, absence of leucocytosis and increased amounts of serum creatinine, aspartate aminotransferase and alanine aminotransferase on admission to the hospital. Previous splenectomy and malignant diseases were not associated with higher mortality. The thrombocytopenia at the time of positive blood culture and the circulatory acidosis as a complication seemed to be independently the most useful predictive factors for a fatal outcome using multivariate logistical regression analysis after adjustment to classic risk factors.

Entities:  

Mesh:

Year:  1992        PMID: 1569306     DOI: 10.1016/0163-4453(92)92850-i

Source DB:  PubMed          Journal:  J Infect        ISSN: 0163-4453            Impact factor:   6.072


  13 in total

1.  Pneumolysin-induced complement depletion during experimental pneumococcal bacteremia.

Authors:  R B Alcantara; L C Preheim; M J Gentry-Nielsen
Journal:  Infect Immun       Date:  2001-06       Impact factor: 3.441

2.  Gram-Positive Pneumonia.

Authors: 
Journal:  Curr Infect Dis Rep       Date:  2000-06       Impact factor: 3.725

3.  Infectious Diseases Society of America/American Thoracic Society consensus guidelines on the management of community-acquired pneumonia in adults.

Authors:  Lionel A Mandell; Richard G Wunderink; Antonio Anzueto; John G Bartlett; G Douglas Campbell; Nathan C Dean; Scott F Dowell; Thomas M File; Daniel M Musher; Michael S Niederman; Antonio Torres; Cynthia G Whitney
Journal:  Clin Infect Dis       Date:  2007-03-01       Impact factor: 9.079

Review 4.  Chronic liver inflammation: clinical implications beyond alcoholic liver disease.

Authors:  Byoung-Jin Park; Yong-Jae Lee; Hye-Ree Lee
Journal:  World J Gastroenterol       Date:  2014-03-07       Impact factor: 5.742

5.  Levels of azithromycin and alpha-1 acid glycoprotein in serum in patients with community-acquired pneumonia.

Authors:  R Bohte; H Mattie; P J van den Broek
Journal:  Antimicrob Agents Chemother       Date:  1995-12       Impact factor: 5.191

6.  Pneumococcal meningitis in the North East Thames Region UK: epidemiology and molecular analysis of isolates.

Authors:  G Urwin; M F Yuan; L M Hall; K Brown; A Efstratiou; R A Feldman
Journal:  Epidemiol Infect       Date:  1996-08       Impact factor: 2.451

7.  The intensive care management, mortality and prognostic indicators in severe community-acquired pneumococcal pneumonia.

Authors:  P D Potgieter; J M Hammond
Journal:  Intensive Care Med       Date:  1996-12       Impact factor: 17.440

Review 8.  Pneumococcal virulence factors: structure and function.

Authors:  M J Jedrzejas
Journal:  Microbiol Mol Biol Rev       Date:  2001-06       Impact factor: 11.056

9.  Efficacy and safety of azithromycin versus benzylpenicillin or erythromycin in community-acquired pneumonia.

Authors:  R Bohte; J W van't Wout; S Lobatto; A Blussé van Oud Alblas; M Boekhout; E H Nauta; J Hermans; P J van den Broek
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1995-03       Impact factor: 3.267

Review 10.  Animal models of Streptococcus pneumoniae disease.

Authors:  Damiana Chiavolini; Gianni Pozzi; Susanna Ricci
Journal:  Clin Microbiol Rev       Date:  2008-10       Impact factor: 26.132

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.